2017 American Transplant Congress
WHO Group II Pulmonary Hypertension Is Associated with Decreased Survival in Patients Awaiting Liver Transplantation.
Medicine, Houston Methodist Hospital, Houston, TX
End stage liver disease (ESLD) patients with cirrhotic cardiomyopathy often have WHO Group II pulmonary hypertension (PH), characterized by pulmonary capillary wedge pressure (PCWP) >15…2017 American Transplant Congress
The Impact of De Novo Post-Transplant Diabetes on Hepatic Steatosis and Liver Transplant Outcomes.
Introduction: As the prevalence of diabetes (DM) increases in the general population, it is also increasing in the transplant (Tx) population. Post-transplant diabetes (PTDM) has…2017 American Transplant Congress
Steroid-Free Immunosuppression After Liver Transplant for Autoimmune Disease Does Not Result in Increased Disease Recurrence.
Immunosuppression regimens in patients with end stage liver disease (ESLD) from autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) typically include…2017 American Transplant Congress
Assessing Self-Efficacy During the Transition from Pediatric to Adult Liver Transplant Care.
University of Michigan, Ann Arbor, MI
Purpose: As part of ongoing quality improvement efforts, this project aimed to investigate changes in self-efficacy among adolescent / young adult liver transplant recipients participating…2017 American Transplant Congress
Effects of Liver Transplantation on Cardiac Function in Patients Transplanted for NASH Cirrhosis.
Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Nonalcoholic Steatohepatitis (NASH) is independently associated with increased cardiovascular events after liver transplantation (LT). NASH is also associated with subclinical myocardial dysfunction in the general…2017 American Transplant Congress
Largest US Series of Minimally Invasive Full and Laparoscopy-Assisted Living Donor Hepatectomy.
Surgery, New York Presbyterian/Columbia University, New York, NY
Columbia University Medical Center (CUMC) has offered minimally invasive donor hepatectomies since 2008. Donor hepatectomies have been performed using 3 access routes (1) hybrid technique;…2017 American Transplant Congress
Unexplained Cost Variation for Liver Transplantation: A National Study of US Transplant Centers.
Background: Liver transplantation is a complex and costly procedure that is the only definitive treatment for irreversible liver disease. Given that transplant admission costs account…2017 American Transplant Congress
Recurrent HCC After Radiofrequency Ablation or Liver Resection Can Be Effectively Treated with Salvage Transplantation.
Background:Liver resection (LR) and radiofrequency ablation (RFA) represent curative therapies for early stages of hepatocellular carcinoma (HCC). If tumour recurrence occurs, salvage liver transplant (SLT)…2017 American Transplant Congress
Down-Regulation of Nuclear HMGB1 by Small Interfering RNA Protects Against Liver Ischemia-Reperfusion Injury.
Background:High mobility group box 1 (HMGB1) was found to have both a beneficial intracellular role and injurious extracellular role after a sterile inflammatory insult.Hepatocyte-specific HMGB1…2017 American Transplant Congress
Biliary Complications Following Liver Transplantation – Single-Center Experience Over Three Decades and Recent Risk Factors.
Core Facility Quality Management Transplantation, Hannover Medical School, Hannover, Germany
This study aims to identify independent risk factors for biliary complications after liver transplantation over 3 decades in a large single center. 1607 consecutive liver…
- « Previous Page
- 1
- …
- 132
- 133
- 134
- 135
- 136
- …
- 180
- Next Page »